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Abstract: Extracellular vesicles
(EVs) are membraneous vesicles
released by a variety of cells into
their microenvironment. Recent
studies have elucidated the role of
EVs in intercellular communication,
pathogenesis, drug, vaccine and
gene-vector delivery, and as possi-
ble reservoirs of biomarkers. These
findings have generated immense
interest, along with an exponential
increase in molecular data pertain-
ing to EVs. Here, we describe
Vesiclepedia, a manually curated
compendium of molecular data
(lipid, RNA, and protein) identified
in different classes of EVs from
more than 300 independent stud-
ies published over the past several
years. Even though databases are
indispensable resources for the
scientific community, recent stud-
ies have shown that more than
50% of the databases are not
regularly updated. In addition,
more than 20% of the database
links are inactive. To prevent such
database and link decay, we have
initiated a continuous community
annotation project with the active
involvement of EV researchers. The
EV research community can set a
gold standard in data sharing
with Vesiclepedia, which could
evolve as a primary resource for
the field.
Introduction
A growing body of research has impli-
cated extracellular vesicles (EVs), mem-
braneous sacs released by a variety of cells,
in diverse physiological and patho-physio-
logical conditions [1–9]. They can be
detected in body fluids including blood
plasma, urine, saliva, amniotic fluid, breast
milk, and pleural ascites [10–13], and
contain proteins, lipids, and RNA repre-
sentative of the host cell [14–18]. Though
a definitive categorization is yet to be
achieved [19], EVs can be broadly classi-
fied into three main classes, based on the
mode of biogenesis: (i) ectosomes (also
referred to as shedding microvesicles), (ii)
exosomes, and (iii) apoptotic bodies (ABs)
(see Box 1).
Recent studies have highlighted the role
of EVs in intercellular communication
[20–22], vaccine and drug delivery [23–
25], and suggested a potential role in gene
vector therapy [26] and as disease bio-
markers [27]. More than three decades of
research has advanced our basic under-
standing of these extracellular organelles
and has generated large amounts of
multidimensional data [14,17]. Whilst
most of the data are presented in the
context of the biological findings/techni-
cal development and are mentioned in the
inline text of the published article, a vast
majority are often placed as supplemen-
tary information or not provided [28,29].
Importantly, none of the molecular data
in published articles is easily searchable
[28]. With the immense interest in EVs
and advances in high-throughput tech-
niques, the data explosion will only
increase. An online compendium of
heterogeneous data will help the biomed-
ical community to exploit the publicly
available datasets and accelerate biologi-
cal discovery [30].
ExoCarta and Need for an EV
Database
Existing databases are not comprehen-
sive. For example, ExoCarta (http://www.
exocarta.org), a database for molecular
data (proteins, RNA, and lipids) identified
in exosomes, catalogs only exosomal
studies (as reported by the authors) [31].
Described initially in 2009 [32], the
database has been visited by more than
16,000 unique users [33]. However, only
exosomal studies (as reported by the
authors) are catalogued in ExoCarta. With
the confusion in terminologies and ineffi-
ciency of the purification protocols to
clearly segregate each class of EVs
[1,19], it is critical to build a repository
with data from all classes of EVs to
understand more about the molecular
repertoire of the various classes of EVs
and their biological functions. This was
the rationale for starting the Vesiclepedia
online compendium for EVs.
Vesiclepedia
Vesiclepedia (http://www.microvesicles.
org) is a manually curated compendium
that contains molecular data identified in
all classes of EVs, including AB, exosomes,
large dense core vesicles, microparticles,
and shedding microvesicles. The main
criterion for manual curation was the
presence of these vesicles in the extracellu-
lar microenvironment (EVs) as approved
by the investigators who undertook the
research. At this juncture, the EVs are
named as per the curated article or
submitting author, as the nomenclature is
yet to be standardized [19]. Vesiclepedia
was built using ZOPE, an open source
content management system. Python a
portable, interpreted, object oriented pro-
gramming language was used in the three-
tier system to connect the web interface
with a MySQL database. Users can query
or browse through proteins, lipids, and
RNAmolecules identified in EVs. Selecting
a gene of interest directs the user to a gene/
molecule page with information on the
gene, its external references to other
primary databases, experiment description
of the study that identified the molecule,
gene ontology based annotations, protein-
protein interactions, and a graphical dis-
play of such network with relevance to
molecules identified in EVs. Gene ontology
annotations of molecular functions, biolog-
ical process, and subcellular localization
were retrieved from Entrez Gene [34] and
mapped onto the proteins/mRNA identi-
fied in EVs. Under the experiment descrip-
tion, the sample source including the tissue
name or cell line name, EV isolation
procedures, and floatation gradient density
as reported in the study are provided to the
users. EV proteins are mapped onto their
protein physical interactors along with the
protein interaction identification method
and PubMed identifier. Protein-protein
interaction data was obtained from HPRD
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[35,36], BioGRID [37], and Human Pro-
teinpedia [38].
Database Issues and
Community Annotation
Though biological databases are indis-
pensable resources for effective scientific
research, it has to be noted that more than
20% of the database links are non-existent
after their initial publication [39–41].
More than 50% of the databases are never
updated reducing their usability [39],
primarily due to the lack of continuous
funding to maintain and update these
resources. At this juncture, funding for
databases is largely non-existent in many
parts of the world. To overcome funding-
related limitations and to keep the data-
base updated, it is essential to involve the
scientific community in annotating the
data. Community annotation will signifi-
cantly ease the burden of the curators who
maintain and update the databases. Whilst
community annotation is the permanent
solution to keep the database updated, it
seldom happens without a clear and
transparent mechanism. In addition, the
system has to ensure continuous deposi-
tion of data and ‘‘not just once’’ uploads. It
has to be noted that data annotation can
be regulated at two levels: (i) principal
investigators voluntarily contributing data
and (ii) peer-reviewed journals mandating
data deposition before publication. Cur-
rently available community annotation
tools don’t have a continuous data depo-
sition arrangement with an investigator.
Additionally, only few journals mandate
the deposition of data to public reposito-
ries before acceptance of a manuscript. To
this end, we have initiated a community
annotation project through Vesiclepedia
that involves members of the EV research
community (53 laboratories from 20
countries: Table 1).
Community annotation via Vesiclepe-
dia happens through the founding mem-
bers who agree to the conditions listed in
Box 2. All of the members are listed in the
credits page (http://www.microvesicles.
org/credits).
On the basis of the agreement of
community participation, members will
submit their data automatically to Vesi-
clepedia before or after publication
(Figure 1). Non-members submitting their
research findings for peer-review through
international journals might find the
Vesiclepedia members as referees who will
request/mandate the authors to submit
the data to Vesiclepedia. By instituting this
mechanism the datasets will be continu-
ously deposited to Vesiclepedia. However,
a non-member can also be appointed as a
referee in which case the data might not
be submitted to Vesiclepedia. The Vesi-
clepedia-data capture team will work
along with the researchers to make the
data submission as easy as possible.
Detailed information on the format of
data required for submission is provided in
the Vesiclepedia webpage (http://www.
microvesicles.org/data_submission). Cur-
rently, Vesiclepedia comprises 35,264
protein, 18,718 mRNA, 1,772 miRNA,
and 342 lipid entries (Table 1). All of these
data were obtained from 341 independent
studies that were published over the past
several years.
Conclusions and Future
Directions
ExoCarta will be active even after the
release of Vesiclepedia and will become a
primary resource for high-quality exoso-
mal datasets. Data deposited to ExoCarta
can also be accessed through Vesiclepedia;
however, only high quality exosomal
datasets deposited to Vesiclepedia can be
accessed through ExoCarta. With the
launch of Vesiclepedia, we expect to have
an organised data deposition mechanism.
We expect active participation from the
EV research community, along with the
addition of new members and numerous
heterogeneous datasets. All datasets sub-
mitted by EV researchers will be listed in
the credits page along with the investigator
details.
Box 1. Categories of EVs Based on the Mode of Biogenesis
Ectosomes or shedding microvesicles: Ectosomes are large EVs ranging
between 50–1,000 nm in diameter [1]. They are shed from cells by outward
protrusion (or budding) of a plasma membrane (PM) followed by fission of their
membrane stalk [3,5]. Ectosomes are released by a variety of cells including
tumour cells, polymorphonuclear leucocytes, and aging erythrocytes [5]. The
expression of phosphatidylserine (PS) on the membrane surface has been shown
to be one of the characteristic features of ectosomes [1,5].
Exosomes: Exosomes are small membranous vesicles of endocytic origin ranging
from 40–100 nm in diameter [1,42]. The density of exosomes varies from 1.10–
1.21 g/ml and the commonly found markers of exosomes are Alix, TSG101,
tetraspanins, and heat shock proteins [10]. The biogenesis of exosomes begins
with the internalisation of molecules via endocytosis [42]. Once internalised,
endocytosed molecules are either recycled to the PM or trafficked to
multivesicular bodies (MVBs) [3]. The ‘‘exocytic’’ fate of MVBs results in their
exocytic fusion with the PM, resulting in the release of intraluminal vesicles into
the extracellular microenvironment as exosomes [43].
Apoptotic bodies: ABs are released from fragmented apoptotic cells and are
50–5,000 nm in diameter [1]. ABs are formed about during the process of
programmed cell death or apoptosis, and represent the fragments of dying cells
[3]. Similar to ectosomes, the expression of PS on the membrane surface has been
shown to be a key characteristic of ABs [1,5].
Table 1. Vesiclepedia statistics.
Statistics n
EV studies 341
Protein entries 35,264
mRNA entries 18,718
miRNA entries 1,772
Lipid molecules 342
Participating laboratories 53
Countries 20
doi:10.1371/journal.pbio.1001450.t001
Box 2. Conditions to Become a Member of Vesiclepedia
Community Annotation
1, Agree to submit datasets pertaining to EVs to Vesiclepedia before or after
publication on a continuous basis
2, When reviewing articles, mandate/request investigators to submit datasets on
EVs to Vesiclepedia
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